AAV-Mediated CRISPR/Cas9 Gene Editing in Murine Phenylketonuria
Phenylketonuria (PKU) due to recessively inherited phenylalanine hydroxylase (PAH) deficiency results in hyperphenylalaninemia, which is toxic to the central nervous system. Restriction of dietary phenylalanine intake remains the standard of PKU care and prevents the major neurologic manifestations...
Main Authors: | Daelyn Y. Richards, Shelley R. Winn, Sandra Dudley, Sean Nygaard, Taylor L. Mighell, Markus Grompe, Cary O. Harding |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-06-01
|
Series: | Molecular Therapy: Methods & Clinical Development |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2329050119301500 |
Similar Items
-
Prospects for Cell-Directed Curative Therapy of Phenylketonuria (PKU)
by: Cary O. Harding
Published: (2019-12-01) -
Mutations of the phenylalanine hydroxylase gene in patients with phenylketonuria in Shanxi, China
by: Yong-An Zhou, et al.
Published: (2012-01-01) -
Long-Term Metabolic Correction of Phenylketonuria by AAV-Delivered Phenylalanine Amino Lyase
by: Rui Tao, et al.
Published: (2020-12-01) -
Spectrum of PAH gene variants among a population of Han Chinese patients with phenylketonuria from northern China
by: Ning Liu, et al.
Published: (2017-10-01) -
Molecular diagnosis of phenylketonuria: From defective protein to disease-causing gene mutation
by: Pavlović Sonja, et al.
Published: (2009-01-01)